Superworth

Medtronic price to free cash flow MDT

Market value divided by free cash flow over the last twelve months, since 2010.

Today, Oct 23, 2026
19.9×
10-year median
23.4×
Against its 10-year history
12th
percentile: 0 is its lowest day, 100 its highest
10-year range
15.6× to 38.2×
Peer median
20.7×

Medtronic's price to free cash flow is 19.9× as of Oct 23, 2026.

That is below its ten-year median of 23.4×, lower than on 88% of days in the last ten years.

Over that time it ranged from 15.6× in Mar 2020 to 38.2× in Apr 2021.

The median for 7 medical device stocks of a similar size is 20.7×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far19.9×17.5×25.4×
202523.8×18.8×25.9×
202418.8×18.8×28.8×
202327.1×20.8×29.0×
202221.4×18.4×26.6×
202124.1×23.4×38.2×
202033.2×15.6×33.2×
201924.1×22.2×26.9×
201824.6×24.1×35.7×
201725.3×19.1×26.1×
201619.8×19.8×29.5×
201521.8×18.7×28.5×
201419.3×12.9×19.7×
201313.3×10.6×14.0×
201210.3×9.7×16.1×
201115.3×14.1×61.3×
201016.4×9.5×16.5×

Against its peers

Companies in Medical - Devices nearest Medtronic's size, closest first, today.

CompanyPrice to free cash flow
MDTMedtronic19.9×
SYKStryker25.1×
ABTAbbott Laboratoriesn/m
BSXBoston Scientific18.3×
EWEdwards Lifesciences35.8×
GEHCGE HealthCare Technologies20.4×
DXCMDexCom20.9×
ZBHZimmer Biomet12.3×
Peer median20.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Medtronic

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.